United Therapeutics gets crucial green light for its flagship drug
July 31, 2018 at 15:12 PM EDT
The approval comes as the Silver Spring's planned acquisition of Israel-based SteadyMed Therapeutics Inc. inches forward, expected to close in the third quarter of this year.
